Vaginal Slings Market
Vaginal Slings Market Size, Share Analysis, By Type (Transobturator Slings, Mini /Single Incision Slings, Conventional Vaginal Slings, Pubovaginal Slings, Others), By Material Type (Tissue & Synthetic Slings), By Type of Urinary Incontinence & By Region - Global Market Insights 2022-2032
Analysis of Vaginal Slings Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Vaginal Slings Market Outlook (2022-2032)
The global vaginal slings market is estimated to be valued at US$ 2.07 billion in 2022, and is forecast to surpass US$ 3.21 billion valuation by the end of 2032, expanding at a CAGR of 4.5% over the 2022 to 2032 projection period.
Vaginal slings are further classified into transobturator slings, mini slings/single incision slings, conventional vaginal slings, advanced vaginal slings, tension-free vaginal tape slings, and pubovaginal slings. Demand for transobturator slings is predicted to rise at a CAGR of 5% from 2022 to 2032. This can be ascribed to their effective advantages over other types, such as low chances of bladder injuries, bowel & major blood artery injuries, and effectiveness comparable to tension-free vaginal tape slings.
In addition to the advantages of these slings, rising rate of the elderly population who are more susceptible to urine incontinence symptoms and increasing prevalence of female urine incontinence are factors boosting the sales of transobturator slings.
- According to the National Center for Biotechnology Information's 2021 study, 423 million people irrespective of their gender (20 and older) globally suffer from urine incontinence across the globe.
Additionally, the growing demand for minimally-invasive surgical procedures is also fuelling product sales growth.
Urinary incontinence, an undetected condition in which the bladder loses control and causes an involuntary flow of pee, is treated with vaginal slings. Some of the behaviours that can cause urine leakage are coughing, laughing, sneezing, lifting heavy objects, and exercising. Vaginal slings support and hold the urethra and bladder like a hammock to stop leakage.
A common type of surgery performed for such conditions is a vaginal sling surgery, where slings are made from natural or synthetic materials such as cadaver tissues, pig or cow tissues, human tissues, or mesh (tissue slings or synthetic slings).
Urinary incontinence symptoms can be seen due to several conditions, including urinary tract infections, weakened pelvic floor muscles and urethral sphincters, menopause, pregnancy, and childbirth.
Furthermore, during the forecast period, the worldwide demand for novel vaginal slings is anticipated to rise due to the rising prevalence of urine incontinence, and technological advancements in vaginal slings. One of the main reasons influencing vaginal sling sales during the projected period is the increased emphasis on minimising maternal death instances and growing healthcare spending power.
As incontinence concerns may emerge during pregnancy and after childbirth, WHO and UNFPA, for instance, have set five essential objectives to minimize unnecessary maternal mortality, which further could support the demand for urethral vaginal slings.
Report Attributes |
Details |
|---|---|
|
Vaginal Slings Market Size (2022E) |
US$ 2.07 Billion |
|
Forecasted Market Value (2032F) |
US$ 3.21 Billion |
|
Global Market Growth Rate (2022-2032) |
4.5% CAGR |
|
China Market Growth Rate (2022-2032) |
8% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Market Trends are Expected to Drive Revenue Growth of Vaginal Sling Solution Manufacturers?
“Rising Worldwide Prevalence of Urinary Incontinence Disorder”
Midurethral sling surgeries are also known as vaginal sling surgeries. This surgical technique is typically carried out for the treatment of urinary incontinence.
Millions of people around the world experience urinary incontinence, a highly widespread urological illness that is both underreported and underdiagnosed. It harms the mental, emotional, and physical health of the patent.
Women are twice as likely to be affected as men, and the prevalence rises with age. Urinary incontinence may be caused due to various reasons, including urethral sphincters, obesity, urinary tract infections, and neurological abnormalities.
The most prevalent type of urine incontinence, stress urinary incontinence, affects millions of people globally. Several studies have revealed that over 45% of women over 30 years of age worldwide experience stress urine incontinence.
There are several types of urine incontinence such as stress urinary incontinence, urge urinary incontinence, and mixed urinary incontinence.
Colposuspension and vaginal mesh were two common but old therapeutic options. However, due to the midurethral sling's reputation as an effective, safe, and efficient procedure, old procedures have been supplanted.
In addition, vaginal sling procedures are gaining popularity because it requires less recovery and operational time. Global manufacturers of vaginal slings are witnessing potential demand opportunities as a result of all these features of the vaginal sling treatment.
What are the Limitations Denting Sales of Vaginal Slings?
“High Risk of UTIs During Vaginal Sling Procedures & Lack of Awareness of Urine Incontinence Treatment”
The potential risks of vaginal sling procedures, such as urinary tract infections (UTIs), together with the decrease in the number of women seeking medical examination and treatment for urine incontinence as a result of social stigma, and also lack of awareness about the treatment procedures in developing regions, could, however, limit business sales growth.
Which Strategies are Followed by Market Newcomers to Achieve High Profits?
“New Market Players Focused on Production of Vaginal Slings with Advanced Features”
New companies are focusing on developing advanced and cost-effective vaginal sling products, to earn a high market share and mark a dominant market position.
A U.S.-based Company Renovia, founded in 2016 is a producer of e-stimulation devices and solutions which focuses on the strengthening of pelvic floor muscles.
The business's solution enables real-time visualisation and treatment of weak pelvic floor muscles. Data management systems and patient-based app technologies are some of the features of the firm's product offerings.
For the treatment of women with stress, mixed, and mild to moderate urinary incontinence, the company offers a leva system and e-stimulation devices, which help to strengthen weak pelvic floor muscles.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Regions are Expected to Be Lucrative Markets for Vaginal Sling Treatment Providers?
“North America & Europe Profitable Markets Due to Large Patient Pool & Rising Prevalence of Neurological Disorders”
North America and Europe are expected to hold a dominating position in the global vaginal slings market during the forecast period. This can be attributed to the factors such as the large patient pool and the presence of major manufacturers of vaginal slings.
Furthermore, the rising geriatric population and rising prevalence of chronic diseases such as diabetes and neurological disorders are boosting the demand for vaginal slings in these regions.
Due to the rapidly improving healthcare infrastructure in nations such as India, China, Japan,South Korea, and Malaysia, the Asia Pacific market is expected to rise at an exponential rate. Additionally, it is anticipated that rising investments by top industry players and healthcare providers will boost the local market in the Asia Pacific region.
Demand for vaginal sling procedures in Latin America and the MEA regions is predicted to rise at a steady pace during the projected period.
Country-wise Analysis
How are Sales of Vaginal Sling Solutions Evolving in European Countries?
“Rising Prevalence of UTIs in European Region Driving Demand for Vaginal Sling Treatment”
Demand for vaginal sling treatment in European countries such as the U.K., Germany, Span, and France is expected to increase due to the rising prevalence of urinary tract infections among women.
- For instance, according to recent research by the National Health Service, between 3-6 million people in the U.K., currently deal with urinary incontinence.
- According to EUROMED research, approx. 6 to 8 million people in Germany currently experience urinary incontinence problems.
Rising incidence of this disease, along with the development of cutting-edge tools for minimally-invasive surgeries, is likely to increase the demand for vaginal mesh sling procedures in the European region.
Why is the United States Expected a Beneficial Marketplace for Suppliers of Vaginal Slings?
“Presence of Advanced Healthcare Infrastructure & Rising Elderly Population with Urinary Disorders”
The United States holds a dominating position in the North American vaginal slings market due to the presence of key manufacturers & the rising senior population with urinary disorders, and advanced healthcare facilities.
- According to recent studies by the National Association for Incontinence, more than 25 million Americans experience daily bladder leakage, with women accounting for the majority of incidences.
Thus, all the above-mentioned factors are expected to increase the demand for vaginal sling surgeries in the U.S. during the forecast period.
Category-wise Analysis
Why is There High Demand for Vaginal Sling Products from Hospitals?
“Existence of Skilled Medical Staff & Medical Technologies in Hospitals”
Vaginal sling surgeries are highly performed in hospitals. This can be attributed to the adoption of highly advanced robot-assisted minimally- invasive surgical equipment.
Governments of several nations across the globe are focusing on advancing their respective healthcare facilities.
- For instance, to assist rural hospitals and promote the rehabilitation and building of rural healthcare institutions, the United States Administration issued $500 million in American Rescue Act grants in 2021.
Over the coming years, developments such as these are projected to drive the overall market dynamics, together with the gradually rising surgical rate in hospitals.
Moreover, target patients primarily prefer hospitals for treatment procedures, due to the presence of advanced technologies and skilled healthcare experts, which subsequently boosts demand for vaginal slings.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Top companies are focusing on producing advanced vaginal sling solutions to increase their market position and earn high a revenue share in the vaginal slings market.
- Boston Scientific Corporation, one of the top market players, has a wide range of product folio with advanced vaginal sling solutions, used in the treatment of urinary disorders.
- For people with stress urine incontinence, Boston Scientific Corporation introduced the AdVance XP Male Sling System in February 2019.
- For instance, Desara TVez, a pelvic sling system developed by Caldera Medical in December 2021 to treat women with stress urinary incontinence and other pelvic health issues, is the latest addition to the Desara family of pelvic sling systems.
Key Segments of Vaginal Slings Industry Research
-
By Type:
- Transobturator Slings
- Mini Slings/Single Incision Slings
- Conventional Vaginal Slings
- Advanced Vaginal Slings
- Tension-free Vaginal Tape Slings
- Pubovaginal Slings
-
By Material Type:
- Tissue Slings
- Synthetic Slings
-
By Type of Urinary Incontinence:
- Urge
- Stress
- Mixed
-
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032 5.3.1. In-Vitro Fertilization (IVF) 5.3.1.1. Fresh Donor 5.3.1.2. Frozen Donor 5.3.1.3. Fresh Non-Donor 5.3.1.4. Frozen Non-Donor 5.3.2. Artificial Insemination 5.3.2.1. Intrauterine Insemination 5.3.2.2. Intracervical Insemination 5.3.2.3. Intravaginal Insemination 5.3.2.4. Intratubal Insemination 5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Type, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-use 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By End-use , 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use , 2022-2032 6.3.1. Fertility Clinics & other settings 6.3.2. Hospitals and others 6.4. Y-o-Y Growth Trend Analysis By End-use , 2017-2021 6.5. Absolute $ Opportunity Analysis By End-use , 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. South Asia 7.3.5. East Asia 7.3.6. Oceania 7.3.7. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By End-use 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By End-use 8.4. Key Takeaways 9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Type 9.2.3. By End-use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By End-use 9.4. Key Takeaways 10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Type 10.2.3. By End-use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By End-use 10.4. Key Takeaways 11. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. India 11.2.1.2. Malaysia 11.2.1.3. Singapore 11.2.1.4. Thailand 11.2.1.5. Rest of South Asia 11.2.2. By Type 11.2.3. By End-use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By End-use 11.4. Key Takeaways 12. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Type 12.2.3. By End-use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By End-use 12.4. Key Takeaways 13. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Type 13.2.3. By End-use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By End-use 13.4. Key Takeaways 14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Type 14.2.3. By End-use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By End-use 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Type 15.1.2.2. By End-use 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Type 15.2.2.2. By End-use 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Type 15.3.2.2. By End-use 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Type 15.4.2.2. By End-use 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Type 15.5.2.2. By End-use 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Type 15.6.2.2. By End-use 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Type 15.7.2.2. By End-use 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Type 15.8.2.2. By End-use 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Type 15.9.2.2. By End-use 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Type 15.10.2.2. By End-use 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Type 15.11.2.2. By End-use 15.12. Singapore 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Type 15.12.2.2. By End-use 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Type 15.13.2.2. By End-use 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Type 15.14.2.2. By End-use 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Type 15.15.2.2. By End-use 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Type 15.16.2.2. By End-use 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Type 15.17.2.2. By End-use 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Type 15.18.2.2. By End-use 15.19. GCC Countries 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Type 15.19.2.2. By End-use 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Type 15.20.2.2. By End-use 15.21. Israel 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2021 15.21.2.1. By Type 15.21.2.2. By End-use 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By End-use 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Cosmos Biomedical Ltd. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Microm U.K. Ltd. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. CooperSurgical, Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. FUJIFILM Irvine Scientific 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Cryolab Ltd. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Vitrolife AB 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. European Sperm Bank 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Bloom IVF Centre 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Merck KGaA 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Ferring B.V. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 02: Global Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 03: Global Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 04: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 05: North America Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 06 North America Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 07: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 08: Latin America Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 09: Latin America Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 11: Europe Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 12: Europe Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 13: South Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: South Asia Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 15: South Asia Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 16: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 17: East Asia Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 18: East Asia Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 19: Oceania Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Oceania Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 21: Oceania Market Value (US$ Mn) Forecast by End-use , 2017-2032
Table 22: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 23: MEA Market Value (US$ Mn) Forecast by Type, 2017-2032
Table 24: MEA Market Value (US$ Mn) Forecast by End-use , 2017-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by Type, 2022-2032
Figure 02: Global Market Value (US$ Mn) by End-use , 2022-2032
Figure 03: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 04: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 05: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 06: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 07: Global Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 08: Global Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 09: Global Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 10: Global Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 11: Global Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 13: Global Market Attractiveness by Type, 2022-2032
Figure 14: Global Market Attractiveness by End-use , 2022-2032
Figure 15: Global Market Attractiveness by Region, 2022-2032
Figure 16: North America Market Value (US$ Mn) by Type, 2022-2032
Figure 17: North America Market Value (US$ Mn) by End-use , 2022-2032
Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 25: North America Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 26: North America Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 28: North America Market Attractiveness by Type, 2022-2032
Figure 29: North America Market Attractiveness by End-use , 2022-2032
Figure 30: North America Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Market Value (US$ Mn) by Type, 2022-2032
Figure 32: Latin America Market Value (US$ Mn) by End-use , 2022-2032
Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 40: Latin America Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 43: Latin America Market Attractiveness by Type, 2022-2032
Figure 44: Latin America Market Attractiveness by End-use , 2022-2032
Figure 45: Latin America Market Attractiveness by Country, 2022-2032
Figure 46: Europe Market Value (US$ Mn) by Type, 2022-2032
Figure 47: Europe Market Value (US$ Mn) by End-use , 2022-2032
Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 55: Europe Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 58: Europe Market Attractiveness by Type, 2022-2032
Figure 59: Europe Market Attractiveness by End-use , 2022-2032
Figure 60: Europe Market Attractiveness by Country, 2022-2032
Figure 61: South Asia Market Value (US$ Mn) by Type, 2022-2032
Figure 62: South Asia Market Value (US$ Mn) by End-use , 2022-2032
Figure 63: South Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 64: South Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: South Asia Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 68: South Asia Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 70: South Asia Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 71: South Asia Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 72: South Asia Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 73: South Asia Market Attractiveness by Type, 2022-2032
Figure 74: South Asia Market Attractiveness by End-use , 2022-2032
Figure 75: South Asia Market Attractiveness by Country, 2022-2032
Figure 76: East Asia Market Value (US$ Mn) by Type, 2022-2032
Figure 77: East Asia Market Value (US$ Mn) by End-use , 2022-2032
Figure 78: East Asia Market Value (US$ Mn) by Country, 2022-2032
Figure 79: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: East Asia Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 83: East Asia Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 85: East Asia Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 86: East Asia Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 88: East Asia Market Attractiveness by Type, 2022-2032
Figure 89: East Asia Market Attractiveness by End-use , 2022-2032
Figure 90: East Asia Market Attractiveness by Country, 2022-2032
Figure 91: Oceania Market Value (US$ Mn) by Type, 2022-2032
Figure 92: Oceania Market Value (US$ Mn) by End-use , 2022-2032
Figure 93: Oceania Market Value (US$ Mn) by Country, 2022-2032
Figure 94: Oceania Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 97: Oceania Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 98: Oceania Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 100: Oceania Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 101: Oceania Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 103: Oceania Market Attractiveness by Type, 2022-2032
Figure 104: Oceania Market Attractiveness by End-use , 2022-2032
Figure 105: Oceania Market Attractiveness by Country, 2022-2032
Figure 106: MEA Market Value (US$ Mn) by Type, 2022-2032
Figure 107: MEA Market Value (US$ Mn) by End-use , 2022-2032
Figure 108: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 109: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 112: MEA Market Value (US$ Mn) Analysis by Type, 2017-2032
Figure 113: MEA Market Value Share (%) and BPS Analysis by Type, 2022-2032
Figure 114: MEA Market Y-o-Y Growth (%) Projections by Type, 2022-2032
Figure 115: MEA Market Value (US$ Mn) Analysis by End-use , 2017-2032
Figure 116: MEA Market Value Share (%) and BPS Analysis by End-use , 2022-2032
Figure 117: MEA Market Y-o-Y Growth (%) Projections by End-use , 2022-2032
Figure 118: MEA Market Attractiveness by Type, 2022-2032
Figure 119: MEA Market Attractiveness by End-use , 2022-2032
Figure 120: MEA Market Attractiveness by Country, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What segments are covered in the vaginal sling market report?
The market is segmented based on type, material type, type of incontinence, end user, and region.
What is the projected market value for vaginal slings?
The global vaginal slings market is projected to reach US$ 3.21 billion by 2032.
At what pace is the vaginal slings market expected to increase over the next 10 years?
Sales of vaginal slings are predicted to increase at 4.5% CAGR from 2022 to 2032.
What is the current market value of vaginal slings?
Worldwide demand for vaginal slings is currently valued at US$ 2.07 billion.
Who are the top players operating in the vaginal sling market?
Some of the key players profiled in the report are Becton, Dickinson Company, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Inc., Coloplast A/S, Cook Medical, Inc., Ethicon US LLC, and ProSurg, Inc.
Vaginal Slings Market